Three quarters of a mile from civilization

Views, analysis & commentary - essentially on venture capital & pharmaceutical industry

Wednesday, December 11, 2013

Crowdfunding good governance

›
Like many other educated, emancipated, intelligent, idealistic denizens out there, I too tended to avoid politics and considered the omnip...
Thursday, November 21, 2013

Will Google deliver on the promise of a Uphone**?

›
A smart phone you can put together like one’d assemble Lego bricks? When I looked up the Phonebloks link my niece sent, it all so...
1 comment:
Tuesday, November 12, 2013

Much appreciated, Namaskaar!

›
I would be kidding if I say the thought never crosses my mind, it does too….., Like many, I’m privy to regular counsel on what’s act...
1 comment:
Sunday, November 10, 2013

So what's wrong if your drug-candidate is likely better-off as a dietary-supplement?

›
In a case-study , the Nov '13 issue of HBR showcases the dilemma of a R&D head grappling with the prospect of a failing clinical p...
Thursday, November 7, 2013

Les Propheties Pharmaceuticale : Prophesying on where the pharmaceutical outsourcing is headed

›
It is either an after-effect of all that powwow with the old-worldly Chippewa ( the ‘real-Indians’, who aren’t Indian really ;-) ) in the ...
Tuesday, October 15, 2013

Deal-Flow : Value-addition :: Silicon-rapids : Organic back-waters

›
Reacting to the rather weird scenario wherein some VCs are trashing their own brotherhood, Bruce Booth wonders in his latest article if t...
1 comment:
Wednesday, October 9, 2013

Isn't 'Syndicate' a worrisome term on an online crowd-funding platform?

›
A recent article by Lora Kolodny on Venture Capital Dispatch raises some interesting aspects on how VCs perceive the impact of likes of A...
‹
›
Home
View web version
Powered by Blogger.